ZURICH (Reuters) - Johnson & Johnson's JNJ.N Cilag Holding will offer up to approximately 11.8 million existing ordinary shares in Idorsia Ltd IDIA.S in an accelerated bookbuilding to commence on Wednesday, the transaction's bookrunner said.
The sale corresponds to approximately 8.3% of Swiss drugmaker Idorsia's outstanding ordinary share capital. Goldman Sachs GS.N will act as sole bookruner on the sale.
Reporting by Brenna Hughes Neghaiwi; Editing by Michael Shields
Our Standards: The Thomson Reuters Trust Principles.